Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

CoinGecko Publishes 2019 Q1 Cryptoasset Report

April 17, 2019 - CoinGecko has announced the publication of its 2019 Q1 cryptoasset report. The 48-page report gives an overview of the state of the cryptoasset market and the major events that happened in the first quarter of 2019. Total market capitalization of all cr...

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...

Powell Testimony Propels Gold Above $1,400 - the Countdown to July’s FOMC Is On

Hot Wednesday is behind us. We had both the Powell’s testimony to the Congress and the released minutes from the latest FOMC meeting. The biggest yesterday’s winner is clearly gold. If you would like to know why – and what situation the yellow m...

EQS Group, EXMceuticals, Media and Games Invest - Buy recommendations from the experts

Analysts' reports on listed companies serve investors as an external source of information. As a rule, research houses publish their recommendations in connection with financing, the publication of financial statements or in order to increase awareness. The information is usua...

Is A Blow-Off Top Setting Up

Our research team has become increasingly concerned that the US Fed support for the markets has pushed price levels well above true valuation levels and that a risk of a downside price move is still rather high. Recently, we published a research article highlighting our Adap...

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...

Gold & Silver “Washout” – Get Ready For A Big Move Higher

Gold and Silver moved lower early on June 2 nd and 3 rd . Our research team believes this is a “Washout Low” price rotation following a technical pattern that will prompt a much higher rally in precious metals. This type of washout price rotation is fa...

How Chinese Trade Issues Will Drive Market Trends

It is becoming evident that the US/Chinese trade issues are going to become a point of contention for the markets going forward. We've been review as much news as possible in an attempt to build a consensus for the future of the US markets and global markets. As of last week, ...

Stockhouse Media Alert: Podcasts from XFUTURE 2019

The Extraordinary Future Conference attracted more than 2,500 attendees to the Vancouver Convention Centre to gain insight from high-profile speakers and analysts on all things emerging from the cannabis and tech sector. And Stockhouse Media covered the event LI...

Eli Lilly Trades Up 15% on Positive Phase 3 Breast Cancer Trial Results

Eli Lilly shares set a new 52-week high price after the company reported that its Verzenio® (abemaciclib) significantly reduced the risk of cancer returning in people with high risk HR+, HER2- early breast cancer. Eli Lilly and Co. (LLY:NYSE) today annou...
1 2 3 4 5 6 7 8 9 10 ...